Scott Ayton, PhD
Scott Ayton, PhD
Florey Institute of Neuroscience and Mental Health
Verified email at
Cited by
Cited by
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
P Lei, S Ayton, DI Finkelstein, L Spoerri, GD Ciccotosto, DK Wright, ...
Nature medicine 18 (2), 291-295, 2012
Current state of Alzheimer’s fluid biomarkers
JL Molinuevo, S Ayton, R Batrla, MM Bednar, T Bittner, J Cummings, ...
Acta neuropathologica 136, 821-853, 2018
Tau-mediated iron export prevents ferroptotic damage after ischemic stroke
QZ Tuo, P Lei, KA Jackman, XL Li, H Xiong, ZY Liuyang, L Roisman, ...
Molecular psychiatry 22 (11), 1520-1530, 2017
A delicate balance: Iron metabolism and diseases of the brain
D Hare, S Ayton, A Bush, P Lei
Frontiers in aging neuroscience 5, 34, 2013
Overcoming the blood–brain barrier: the role of nanomaterials in treating neurological diseases
D Furtado, M Björnmalm, S Ayton, AI Bush, K Kempe, F Caruso
Advanced materials 30 (46), 1801362, 2018
Metallostasis in Alzheimer's disease
S Ayton, P Lei, AI Bush
Free Radical Biology and Medicine 62, 76-89, 2013
Ferroptosis and cell death mechanisms in Parkinson's disease
SJ Guiney, PA Adlard, AI Bush, DI Finkelstein, S Ayton
Neurochemistry international 104, 34-48, 2017
Ferritin levels in the cerebrospinal fluid predict Alzheimer’s disease outcomes and are regulated by APOE
S Ayton, NG Faux, AI Bush
Nature communications 6 (1), 6760, 2015
Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease
S Ayton, P Lei, JA Duce, BXW Wong, A Sedjahtera, PA Adlard, AI Bush, ...
Annals of neurology 73 (4), 554-559, 2013
Tau protein: relevance to Parkinson's disease
P Lei, S Ayton, DI Finkelstein, PA Adlard, CL Masters, AI Bush
The international journal of biochemistry & cell biology 42 (11), 1775-1778, 2010
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
S Ayton, A Fazlollahi, P Bourgeat, P Raniga, A Ng, YY Lim, I Diouf, ...
Brain 140 (8), 2112-2119, 2017
Iron and Alzheimer’s disease: an update on emerging mechanisms
DJR Lane, S Ayton, AI Bush
Journal of Alzheimer's Disease 64 (s1), S379-S395, 2018
Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology
S Ayton, Y Wang, I Diouf, JA Schneider, J Brockman, MC Morris, AI Bush
Molecular psychiatry 25 (11), 2932-2941, 2020
GSK-3 in neurodegenerative diseases
P Lei, S Ayton, AI Bush, PA Adlard
International journal of Alzheimer’s disease 2011, 2011
Ferroptosis and its potential role in the physiopathology of Parkinson’s Disease
L Mahoney-Sánchez, H Bouchaoui, S Ayton, D Devos, JA Duce, ...
Progress in neurobiology 196, 101890, 2021
The hypoxia imaging agent CuII(atsm) is neuroprotective and improves motor and cognitive functions in multiple animal models of Parkinson’s disease
LW Hung, VL Villemagne, L Cheng, NA Sherratt, S Ayton, AR White, ...
Journal of Experimental Medicine 209 (4), 837-854, 2012
Nigral iron elevation is an invariable feature of Parkinson’s disease and is a sufficient cause of neurodegeneration
S Ayton, P Lei
BioMed research international 2014, 2014
Motor and cognitive deficits in aged tau knockout mice in two background strains
P Lei, S Ayton, S Moon, Q Zhang, I Volitakis, DI Finkelstein, AI Bush
Molecular neurodegeneration 9 (1), 1-12, 2014
The essential elements of Alzheimer’s disease
P Lei, S Ayton, AI Bush
Journal of Biological Chemistry 296, 2021
Biometals and their therapeutic implications in Alzheimer’s disease
S Ayton, P Lei, AI Bush
Neurotherapeutics 12, 109-120, 2015
The system can't perform the operation now. Try again later.
Articles 1–20